| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―May―27 |
Organizational and clinical aspects of acute coronary syndrome combined with a new coronavirus infection (SARS-COV-2) |
I. I. Serebrennikov, Ph. Yu. Kopylov, R. N. Komarov, M. B. Mukanova, A. M. Ismailbaev, F. S. Gafurov |
| 2 |
[GO] |
2023―Mar―03 |
Effects of the combined use of atorvastatin and curcetin on inflammatory biomarkers in patients with unstable angina after COVID-19 (“Long COVID”) |
R. B. Alieva, Kh. G. Fozilov, A. B. Shek, Sh. U. Khoshimov, M. M. Musabaev, L. E. Kan, et al. (+2) A. R. Kim, Sh. A. Khodimetova |
| 3 |
[GO] |
2022―Oct―12 |
Features of myocardial damage at COVID-19 |
S. H. Hamidov, A. G. Obrezan, P. S. Lobanova, S. V. Azarenko |
| 4 |
[GO] |
2022―Oct―12 |
Features of the manifestation of arterial hypertension in patients with a new coronavirus infection |
T. D. Solnceva, A. A. Lachugin, O. A. Sivakova, I. E. Chazova |
| 5 |
[GO] |
2022―May―29 |
Two case reports: clinical experience with fixed combinations of indapamide/perindopril and amlodipine/perindopril in patients with arterial hypertension during the COVID-19 pandemic |
S. Ia. Tazina, I. A. Belyaev, T. A. Fedorova, N. A. Semenenko, S. A. Tazin |
| 6 |
[GO] |
2021―Nov―26 |
COVID-19 pandemic challenges: on the way to overcome obstacles in realization of PAH-specific therapy treatment goals |
E. A. Rezukhina, I. Z. Korobkova, N. M. Danilov, V. V. Gramovich, T. V. Martynyuk |
| 7 |
[GO] |
2020―May―26 |
MANAGEMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE PANDEMIC OF A NEW CORONAVIRUS INFECTION |
T. V. Martynyuk, A. M. Aleevskaya, O. V. Rodnenkov, A. V. Zorin, A. M. Kasparova, S. N. Nakonechnikov, I. E. Chazova |
